ET Healthworld: Reduced GST on cancer drugs: Step towards greater affordability

Published : 11 September, 2024


In an industry article published in ET HealthWorld , Mr. D. S. Negi, CEO, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), along with Dr. Vineet Talwar, Director, Department of Medical Oncology, RGCIRC shared their views on the central government’s recent announcement of reduction in GST rates from 12% to 5% on cancer drugs following 54th GST Council meeting. They emphasised on how GST reduction on lifesaving drugs will help in making cancer treatment affordable.

Read More

 

Read More

 

Read More


Opportunity to Help

DONATE FOR CANCER CARE

As a society, RGCIRC is looking forward to get support from generous people

Read More
DONATE BLOOD

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More
DONATE TIME (VOLUNTEER)

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

Sir Chotu Ram Marg, Sector - 5, Rohini Industrial Area, Rohini, New Delhi - 110085, India | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7 All weekdays

Squadron Leader Mahendra Kumar Jain Marg, Block K, Niti Bagh, New Delhi - 110049 | +91-11-45822222
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7 All Weekdays

Subscribe Today For Our Healthy Tips Newsletter
Loading